Open | - |
Close | - |
Volume / Avg. | 500.000 / 235.689K |
Day Range | - - - |
52 Wk Range | 4.545 - 27.720 |
Market Cap | $1.128B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | % |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Silence Therapeutics (NASDAQ: SLN) through any online brokerage.
Other companies in Silence Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Immunome (NASDAQ:IMNM), 89bio (NASDAQ:ETNB), Zentalis Pharma (NASDAQ:ZNTL) and Centessa Pharmaceuticals (NASDAQ:CNTA).
The latest price target for Silence Therapeutics (NASDAQ: SLN) was reported by HC Wainwright & Co. on Friday, March 15, 2024. The analyst firm set a price target for 75.00 expecting SLN to rise to within 12 months (a possible 209.28% upside). 18 analyst firms have reported ratings in the last year.
The stock price for Silence Therapeutics (NASDAQ: SLN) is $24.25 last updated Today at March 19, 2024 at 8:32 AM EDT.
There are no upcoming dividends for Silence Therapeutics.
Silence Therapeutics’s Q1 earnings are confirmed for Tuesday, May 14, 2024.
There is no upcoming split for Silence Therapeutics.
Silence Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.